相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma
Thomas A. Ollila et al.
BLOOD (2021)
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study
Adam S. Zayac et al.
HAEMATOLOGICA (2021)
Ineffectiveness of high-dose methotrexate for prevention of CNS relapse in diffuse large B-cell lymphoma
Robert Puckrin et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
Andrew M. Evens et al.
BLOOD (2021)
Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review
Toby A. Eyre et al.
HAEMATOLOGICA (2020)
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery
Matthew R. Wilson et al.
BLOOD ADVANCES (2020)
Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity
Toby A. Eyre et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
B-Cell Lymphomas, Version 3.2019 Featured Updates to the NCCN Guidelines
Andrew D. Zelenetz et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of CNS Relapse Treated in the Rituximab Era
Sabela Bobillo et al.
BLOOD (2019)
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL
Magdalena Klanova et al.
BLOOD (2019)
Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma
David Qualls et al.
HAEMATOLOGICA (2019)
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma
Tarec Christoffer El-Galaly et al.
EUROPEAN JOURNAL OF CANCER (2018)
Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)
Francisco-Javier Penalver et al.
HAEMATOLOGICA (2017)
Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)
Francisco-Javier Penalver et al.
HAEMATOLOGICA (2017)
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy et al.
BLOOD (2016)
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
Kerry J. Savage et al.
BLOOD (2016)
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
Norbert Schmitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis-A Systematic Review of Prospective Studies
Abhimanyu Ghose et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Zheng Zhou et al.
BLOOD (2014)
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma
C. Y. Cheah et al.
BRITISH JOURNAL OF CANCER (2014)
Intravenous Methotrexate as Central Nervous System (CNS) Prophylaxis Is Associated With a Low Risk of CNS Recurrence in High-Risk Patients With Diffuse Large B-Cell Lymphoma
Jeremy S. Abramson et al.
CANCER (2010)
Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516-The Southwest Oncology Group
Steven H. Bernstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study
Peter C. Austin et al.
STATISTICS IN MEDICINE (2007)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)
分享论文
